A synthetic peptide for use as a blocking control in assays to test for specificity of CEACAM6 antibody, Alternative Names: CEACAM6 control peptide, CEACAM6 antibody Blocking Peptide, Anti-CEACAM6 Blocking Peptide, Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6 Blocking Peptide, CD66c Blocking Peptide, CEAL Blocking Peptide, NCA Blocking Peptide
Many breast, pancreatic, colonic and non-small-cell lung carcinoma lines express CEACAM6 and CEACAM5, and antibodies to both can affect tumor cell growth in vitro and in vivo. CEACAM6 expression is elevated in many solid tumors, but variable as a function of histotype. It may be a promising target for antibody-based therapy.